ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 288.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$394M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
251
New
Increased
Reduced
Closed

Top Buys

1 +$27.6M
2 +$20.5M
3 +$17.4M
4
ETNB
89bio
ETNB
+$12.6M
5
JANX icon
Janux Therapeutics
JANX
+$7.04M

Top Sells

1 +$105M
2 +$14.6M
3 +$7.97M
4
SAGE
Sage Therapeutics
SAGE
+$6.58M
5
VERV
Verve Therapeutics
VERV
+$5.27M

Sector Composition

1 Healthcare 87.7%
2 Financials 1.74%
3 Communication Services 0.1%
4 Consumer Discretionary 0.1%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
201
Ardelyx
ARDX
$1.46B
-915,130
ARGX icon
202
argenx
ARGX
$49B
-1,759
AUPH icon
203
Aurinia Pharmaceuticals
AUPH
$2.15B
-10,000
AVXL icon
204
Anavex Life Sciences
AVXL
$307M
-16,221
BCAB icon
205
BioAtla
BCAB
$8.55M
-3,410
BOLT icon
206
Bolt Biotherapeutics
BOLT
$9.17M
-10,823
BPMC
207
DELISTED
Blueprint Medicines
BPMC
-15,000
CASI
208
DELISTED
CASI Pharmaceuticals
CASI
-44,120
CLBR
209
DELISTED
Colombier Acquisition Corp II
CLBR
-10,000
CNTB
210
Connect Biopharma Holdings
CNTB
$142M
-10,300
CRMD icon
211
CorMedix
CRMD
$579M
-175,000
DSGN icon
212
Design Therapeutics
DSGN
$788M
-42,408
ELDN icon
213
Eledon Pharmaceuticals
ELDN
$272M
-16,900
EMCGR
214
DELISTED
Embrace Change Acquisition Corp Rights
EMCGR
-13,144
EMCGW
215
DELISTED
Embrace Change Acquisition Corp Warrants
EMCGW
-18,000
ENGN icon
216
enGene Therapeutics
ENGN
$545M
-27,787
EPIX
217
DELISTED
ESSA Pharma
EPIX
-50,000
INMB icon
218
INmune Bio
INMB
$36.7M
0
INZY
219
DELISTED
Inozyme Pharma
INZY
-37,161
IOVA icon
220
Iovance Biotherapeutics
IOVA
$1.43B
0
ITOS
221
DELISTED
iTeos Therapeutics
ITOS
-26,937
KVAC icon
222
Keen Vision Acquisition Corp
KVAC
$111M
-75,000
KVACW icon
223
Keen Vision Acquisition Corp Warrant
KVACW
$265K
-75,000
KYMR icon
224
Kymera Therapeutics
KYMR
$7.12B
-13,366
MOVE icon
225
Corvex Inc
MOVE
$1.1B
-2,600